Table 2.
Visual acuity outcomes (LOCF) for all patients stratified by country, subgroups and injections
| n | Mean baseline visual acuity score (letters) | Mean change in visual acuity at month 12 (letters) | 95% CI | |
|---|---|---|---|---|
| First‐year completers | 562 | 59.4 | 4.4 | 3.3–5.4 |
| Countrya | ||||
| France | 56 | 60.7 | 4.5 | 0.9–8.1 |
| Germany | 95 | 61.4 | 3.9 | 1.2–6.6 |
| Greece | 32 | 61.6 | 3.4 | −0.3 to 7.1 |
| Portugal | 5 | 57.6 | 0.0 | −10.5 to 10.5 |
| Russia | 39 | 44.1 | 8.4 | 3.5–13.2 |
| Slovakia | 137 | 62.0 | 3.1 | 1.5–4.6 |
| Spain | 73 | 56.9 | 4.8 | 2.2–7.5 |
| UK | 125 | 60.3 | 5.1 | 2.5–7.7 |
| Sexa | ||||
| Male | 327 | 62.0 | 4.5 | 3.1–5.8 |
| Female | 235 | 55.9 | 4.3 | 2.6–6.0 |
| Agea | ||||
| <65 years | 268 | 59.6 | 4.5 | 3.0–6.1 |
| ≥65 years | 294 | 59.3 | 4.2 | 2.8–5.6 |
| Baseline visual acuity score categoriesa | ||||
| ≤60 letters | 266 | 46.3 | 8.8 | 7.2–10.4 |
| 61–73 letters | 182 | 67.4 | 1.5 | –0.0 to 2.9 |
| >73 letters | 114 | 77.3 | –1.1 | –3.1 to 0.8 |
| Injection categories (4‐level)a | ||||
| <4 | 184 | 58.6 | 4.6 | 2.9–6.3 |
| 4–5 | 156 | 60.4 | 4.3 | 2.2–6.5 |
| 6–7 | 116 | 59.6 | 4.4 | 2.1–6.7 |
| >7 | 106 | 59.2 | 4.0 | 1.6–6.4 |
CI = confidence interval, SD = standard deviation.
First‐year completers.